State officials have been urged by federal drug
regulators to close loopholes that could affect the safety of compounded drugs.
FDA has approached state health and pharmacy board officials with a plan that
will hopefully be turned into legislation by Congress. The new regulations
would give the agency clearer congressionally mandated authority to regulate the
compounding pharmacies.
Drug compounding occurs when a licensed pharmacist alters or recombines drug products in response to a physicians’ prescription for a specific patient. This is generally used when the patient is unable to take the standard version of a treatment due to age, allergies and other conditions. Some compounding pharmacies have dramatically expanded into large-scale production, but regulations have not kept up with the expansion, leaving these pharmacies without the stringent safety and efficacy standards that are imposed on drug makers by the FDA.
Continue to read here
Drug compounding occurs when a licensed pharmacist alters or recombines drug products in response to a physicians’ prescription for a specific patient. This is generally used when the patient is unable to take the standard version of a treatment due to age, allergies and other conditions. Some compounding pharmacies have dramatically expanded into large-scale production, but regulations have not kept up with the expansion, leaving these pharmacies without the stringent safety and efficacy standards that are imposed on drug makers by the FDA.
Continue to read here
No comments:
Post a Comment